JA NHG HAZMAT_Redacted.pdf

This is a Justification and Approval (J&A) Modified document for a sole source acquisition by the Defense Health Agency Contracting Activity (DHACA) for the Naval Hospital Guam. The requirement is to procure Point of Care reagents, Cytology/Histology reagents, bacteriology supplies, hematology stains, and medical drug screen reagents to support the hospital's laboratory operations. The contract will be awarded to International Hospital Supply Corp (IHS), a small business, using Federal Acquisition Regulation (FAR) Subpart 13.501 simplified acquisition procedures.

The procurement will be a firm fixed-price contract with four option years, each covering a 12-month supply period ending September 30th from 2026 to 2030. The solicitation (HT941025Q2093) was issued with a 100% small business set-aside, but previous attempts to award the contract failed when another vendor (ATC Procurement LLC) could not fulfill shipping requirements. Market research conducted in May and July 2025 determined that IHS is the only vendor capable of meeting the laboratory's specific needs, with a proven track record of delivering hazardous materials and maintaining cold-chain custody for specialized medical supplies.